Insider Trading Activity For SAGE Therapeutics Inc (NASDAQ:SAGE)
Steven M Paul , Director of SAGE Therapeutics Inc (NASDAQ:SAGE) reportedly Sold 49,461 shares of the company’s stock at an average price of 161.02 for a total transaction amount of $7,964,210.22 SEC Form
Insider Trading History For SAGE Therapeutics Inc (NASDAQ:SAGE)
Recent Trading Activity for SAGE Therapeutics Inc (NASDAQ:SAGE)
Shares of SAGE Therapeutics Inc closed the previous trading session at with 148.51 shares trading hands.